These results collectively indicate a close and important relationship between PRKAG1 and the tumor immune microenvironment, and it may influence HCC progression by regulating the MIF-(CD74+CXCR4) signaling pathway. This evidence concerns the gene PRKAG1 and hepatocellular carcinoma.